Dr. Annabelle Forsmark

Dr. Annabelle Forsmark

Senior manager Health Economics and Outcomes Research

PharmaLex Sweden

Annabelle works as a Senior Manager within Health Economics and Outcomes Research (HEOR) at PharmaLex. She has more than 7 years’ experience from market access and reimbursement, with special interest in Advanced Therapy Medicinal Products (ATMP) and orphan diseases. Annabelle joined PharmaLex after 10 years in academical research and has a doctorate degree in Cell and Molecular biology.

At PharmaLex, Annabelle has managed projects within a range of therapeutic areas (e.g. muscular dystrophies, epilepsy, spasticity, chronic anaemias, robotic surgery etc.) regarding reimbursement, market access, strategic advice, Real World Evidence (RWE) and health economic modelling etc. The projects have been on behalf of pharmaceutical industry, public authorities or healthcare. Some of the collaborations have resulted in peer-reviewed publications, authored or co-authored by Annabelle.

The work with reimbursement processes has meant frequent interactions with the competent bodies in the Nordic countries and vast experience from preparing submissions to conform with the specific requirements of the respective HTA authorities (TLV, DMA/DMC, NoMA and HILA/Fimea).

Other speakers in 2020

Alexander Lezhava


Alexander Lezhava, PhD

Associate Director, Office of Strategic Alliances & Knowledge Management, Genome Institute of Singapore
Senior Group Leader, Translational Research Group, Genome Institute of Singapore
Colin Mcguckin


Colin McGuckin, Prof. Dr.

Founding Director, Chairman and Chief Scientific Officer
CTI-Biotech Cell Therapy Research Institute, Lyon, France
Prof. Dr. Asen Dudov


Prof. Dr. Asen Dudov

President of the Bulgarian Cancer Scientific Society (BCSS)
Medical Director and Head of Medical Oncology Department, Acibadem City Clinic Mladost
Skip to content